表表1:核心值..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................
目录 致谢 ................................................................................................................................................ iv 摘要 ...................................................................................................................................................... v 缩写表 ................................................................................................................................................ ix 符号表 ................................................................................................................................................ xi 图表表 ................................................................................................................................................ xiiii 表格表 ................................................................................................................................................ xix
表1:撒哈拉以南非洲医疗保健领域中使用的常见技术表2:远程医疗和远程患者监测计划的非避免列表表3:非详尽的医疗保健操作和管理计划列表
标题页面页面声明确认摘要摘要摘要摘要表表的表清单符号列表/符号列表/缩写/词汇/词汇/术语案例清单列表法规清单(法规清单)文字清单(第1、2、2、3、3、4、4、4、4、4、4,5…)
表格列表表 2-1. 设计挑战................................................................................................................................................................ 7 表 2-2. 其他相关资料................................................................................................................................................. 7 表 3-1. 器件建议....................................................................................................................................................... 10 表 3-2. 设计挑战....................................................................................................................................................... 10 表 3-3. 相关资料....................................................................................................................................................... 10 表 4-1. 设计挑战....................................................................................................................................................... 13 表 4-2. 相关资料....................................................................................................................................................... 13 表 5-1. 器件建议....................................................................................................................................................... 17 表 5-2. 设计挑战....................................................................................................................................................... 18 表 5-3. 相关资料....................................................................................................................................................... 18
表列表表1:parpi指示批准了HSE(01/11/2023)需要测试的销售费…… Requirements………………………………………………………………………………..7 Table 3b Ovarian Cancer PARP; Testing Requirements…………………………………………………………………………….8 Table 3c Prostate Cancer PARPi Testing Requirements…………………………………………………………………………….9 Table 4a BREAST CANCER: Possible Germline BRCA testing results and Referral to Cancer Genetics Services………………………………………………………………………………………………………………………………………………… 13 Table 4b OVARIAN Cancer: Possible tumour BRCA and HRD testing results and Referral to Cancer Genetics服务…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………”服务…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………
表编号描述表1缩写列表表2美国糖尿病协会“ ADA”的证据级别表3肾脏疾病的证据级别改善了全球结果“ KDIGO”表4国际工作组的糖尿病上工作组的证据级别“ IWGDF”的“ IWGDF”的证据级别“ IWGDF”表5妊娠糖尿病的诊断标准表10诊断糖尿病和糖尿病前期的标准表11糖血症目标表12胰岛素的各种方案的特征13使用表14使用表14使用的特征及其特征性的iNsigation in Insgy in Instot in Insgy in Insgy in Instrict in Instrict in Instrict in Insgy in Instrict in Insgy insigation Insgy in Instry in Instry interpt胰高血糖状肽-1受体激动剂表表17关于切换胰岛素产品的建议表18口腔抗糖尿病药物组表19抗糖尿病类别的最重要技巧表20监测标准和频率表21低血糖分类表22低血糖症状症状应表23低血糖治疗技巧,以至于患者表24疾病及其疾病的杂物24差异化蛋白综合征表25糖尿病神经病分类表26用于预防的他汀类药物疗法表27糖尿病足分类表28风险分层系统和(IWGDF)的脚部筛查频率(IWGDF)表29糖尿病脚感染的潜在经验治疗
表和图表表1。Total number students in each college ................................................................................... 1 Table 2.由政府,自然和其他奖学金资助的学生总数.......................................................................................................................................................................................................................................Total intake of student in the year 2024 ................................................................................. 3 Table 4.预计2025年和2026年的毕业生总数.........................................................................................................................................................................................................................Total number of staffs at Royal University of Bhutan .............................................................. 6 Table 6.Total number of Academic staff with qualification ................................................................... 7 Table 7.长期研究的员工总数(学术和行政和技术)................................................... 7表8。学术人员的资金来源清单........................................................................................................................................................................................................................................................................... 8表9。完成长期研究的学术人员总数。............................................... 9 Table 10.Total Academic staff on campus .........................................................................................10 Table 11.库RUB所提供的各种计划的列表................................................................................................................................................................................................................................................................... 11
此列表表明了处方药的常见用途。有些药物用于治疗多种疾病。本文件包含对品牌处方药的引用,这些处方药是与 CVS Caremark® 无关的制药商的商标或注册商标。列出的产品仅供参考,并不旨在取代处方者的临床判断。针对性治疗类别和特定药物靶点可能会根据新药上市、产品批准、药物撤回和其他市场变化而发生变化。计划成员的隐私对我们很重要。我们的员工接受了有关如何正确处理会员私人健康信息的培训。©2023 CVS Health 和/或其附属公司之一。保留所有权利。75-33960A 101923